Gainers

• Concord Medical Services (NYSE:CCM) shares increased by 24.9% to $6.63 during Friday's after-market session. The market value of their outstanding shares is at $254.4 million.
• Tempest Therapeutics (NASDAQ:TPST) shares increased by 10.54% to $11.21. The company's market cap stands at $49.2 million.
• Atara Biotherapeutics (NASDAQ:ATRA) stock increased by 9.92% to $16.28. The market value of their outstanding shares is at $107.0 million.
• OmniAb (NASDAQ:OABI) shares increased by 7.22% to $1.78. The market value of their outstanding shares is at $244.7 million.
• Evaxion (NASDAQ:EVAX) shares moved upwards by 7.06% to $7.27. The company's market cap stands at $60.6 million.
• Entero Therapeutics (NASDAQ:ENTO) stock moved upwards by 6.85% to $5.3. The market value of their outstanding shares is at $10.3 million.

Losers

• XORTX Therapeutics (NASDAQ:XRTX) shares decreased by 20.0% to $0.88 during Friday's after-market session. The market value of their outstanding shares is at $4.4 million.
• Synlogic (NASDAQ:SYBX) stock declined by 12.57% to $1.6. The company's market cap stands at $19.8 million.
• Universe Pharmaceuticals (NASDAQ:UPC) stock declined by 12.24% to $4.59. The market value of their outstanding shares is at $82.9 million.
• Equillium (NASDAQ:EQ) shares decreased by 9.68% to $1.32. The market value of their outstanding shares is at $43.9 million.
• Femasys (NASDAQ:FEMY) shares decreased by 9.5% to $0.64. The company's market cap stands at $24.2 million.
• rYojbaba (NASDAQ:RYOJ) shares fell 8.7% to $4.41. The market value of their outstanding shares is at $53.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.